Home > Riviste > International Angiology > Fascicoli precedenti > Articles online first > International Angiology 2017 Mar 14

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Estratti

INTERNATIONAL ANGIOLOGY

Rivista di Angiologia


Official Journal of the International Union of Angiology, the International Union of Phlebology and the Central European Vascular Forum
Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,899


eTOC

 

International Angiology 2017 Mar 14

DOI: 10.23736/S0392-9590.17.03824-X

Copyright © 2017 EDIZIONI MINERVA MEDICA

lingua: Inglese

Mitochondrial dysfunction in calf muscles of patients with combined peripheral arterial disease and diabetes type 2

Brian LINDEGAARD PEDERSEN 1, Niels BÆKGAARD 1, Bjørn QUISTORFF 2

1 Department of Vascular Surgery, Rigshospitalet, Gentofte Hospital, Gentofte, Denmark; 2 Nuclear Magnetic Resonance Centre, Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark


PDF  


BACKGROUND: This study elucidate the effects on muscle mitochondrial function in patients suffering from combined peripheral arterial disease (PAD) and type 2 diabetes (T2D) and the relation to patient symptoms and treatment.
METHODS: Near Infra Red Spectroscopy (NIRS) calf muscle exercise tests were conducted on Forty subjects, 15 (PAD), 15 (PAD+T2D) and 10 healthy age matched controls (CTRL) recruited from the vascular outpatient clinic at Gentofte County Hospital, Denmark. Calf muscle biopsies (~ 80 mg) (Gastrocnemius and Anterior tibial muscles) were sampled and mitochondrial function tested applying high resolution oxygraphy on isolated muscle fibers.
RESULTS: The NIRS exercise tests showed evidence of mitochondrial dysfunction in the PAD+T2D group by a longer recovery of the deoxygenation resulting from exercise in spite of a higher exercise oxygenation level compared to the PAD group. This was confirmed by a ~30% reduction in oxygen consumption in the muscle biopsy tests for the PAD+T2D compared to the PAD group (P<0.05). We claim that this mitochondrial dysfunction partly explains the ~30% reduction in tread mill walking distance for the PAD+T2D group observed in this study.
CONCLUSIONS: These findings support the use of early surgical revascularization in the PAD+T2D group, in order to obtain better walking performance and probably reduced risk of permanent mitochondrial damage.


KEY WORDS: PAD - T2D - Muscle biopsies - Mitochondrial function - NIRS

inizio pagina

Publication History

Per citare questo articolo

Corresponding author e-mail

Brian.Lindegaard.Pedersen.01@regionh.dk